Calyxt NASDAQ CLXT
$19.51 -0.75 -3.84%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 13 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

414.57M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

411.24M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.89
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

21.25M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-
Upcoming events Calyxt All events
No upcoming events scheduled

Stock chart Calyxt

Stock analysis Calyxt

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-12.58 14.25
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
57.32 4.13
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-12.99 9.88
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.11 0.10
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-6.80 9.52

Price change Calyxt per year

2.96$ 12.43$
Min Max

Summary analysis Calyxt

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Calyxt

Revenue and net income Calyxt

All parameters

About company Calyxt

Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to support various research projects; and a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and various geographies outside the United States. It also has a strategic alliance with J.R. Simplot Company to drive new breeding techniques for strawberries, including gene editing. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
Address:
2800 Mount Ridge Road, Roseville, MN, United States, 55113-1127
Company name: Calyxt
Issuer ticker: CLXT
ISIN: US13173L1070
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2017-07-20
Sector: Healthcare
Industry: Biotechnology
Site: https://www.calyxt.com

On which stock exchange are Calyxt (CLXT) stocks traded?

Calyxt (CLXT) stocks are traded on NASDAQ.

What is the ticker of Calyxt stocks (CLXT)?

The stock ticker of Calyxt’s stocks or in other words, the code is CLXT. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Calyxt (CLXT) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Calyxt (CLXT) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Calyxt (CLXT) stocks traded?

Calyxt (CLXT) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Calyxt (CLXT) stocks today?

The current price of Calyxt stocks on 29.03.2024 is 19.51 dollars. per share.

What is the dynamics of Calyxt (CLXT) stocks from the beginning of the year?

Calyxt (CLXT) quotes have increased by 0% from the beginning of the year up to 19.51 dollars. per 1 stocks.

How much did Calyxt (CLXT) stocks increase in марте 2024?

This month Calyxt (CLXT) quotes have increased by 0% to 19.51 dollars. per share.

How much are Calyxt (CLXT) stocks worth?

Today, on October, 29.03.2024 Calyxt’s (CLXT) stocks cost 19.51 dollars..

What is the market capitalization of Calyxt (CLXT)?

Capitalization is the market value of Calyxt (CLXT) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.03.2024, the market capitalization of Calyxt (CLXT) is estimated at about 414568712 dollars.